Entry price: 139.28
Fundamentals:
- Sector: Medical - Biotech
- EPS % Chg (Last Qtr): 42%
- EPS % Chg (Previous Qtr): 124%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 216%
- Sales % Chg (Previous Qtr): 155%
- 3-Year Sales Growth Rate: 447%
- Annual Pre -Tax Margin: -385%